PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
/C O R R E C T I O N -- Ranok Therapeutics/
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Biond Biologics and Guangzhou-Israel Biotechnology Fund ("GIBF") Announce Closing of $8 Million Investment and Collaboration
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Driving Innovation, Empowering Partners: ACROBiosystems Showcases Comprehensive CGT Solutions Anchored by GMP Capabilities at Bio Korea 2026
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ASCO 2026 | Oricell's GPC3 CAR-T Ori-C101 Hits 66.7% ORR in Late-Line HCC, Signaling Best-in-Class Potential
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in Untreated NSCLC
2026-06-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved